(19)
(11) EP 1 232 172 A1

(12)

(43) Date of publication:
21.08.2002 Bulletin 2002/34

(21) Application number: 00980179.6

(22) Date of filing: 14.11.2000
(51) International Patent Classification (IPC)7C07H 19/04, A61K 31/7064, A61P 7/02
(86) International application number:
PCT/SE0002/230
(87) International publication number:
WO 0103/6438 (25.05.2001 Gazette 2001/21)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 15.11.1999 SE 9904128

(71) Applicant: AstraZeneca AB
151 85 Södertälje (SE)

(72) Inventors:
  • HARDERN, David,AstraZeneca R & D Charnwood
    Loughborough,Leics. LE11 5RH (GB)
  • INGALL, Anthony,AstraZeneca R & D Charnwood
    Loughborough,Leics. LE11 5RH (GB)
  • WILLIS, Paul,AstraZeneca R & D Charnwood
    Loughborough,Leics. LE11 5RH (GB)

   


(54) NOVEL RIBOSE COMPOUNDS